Cargando…
Development of a Framework Based on Reflective MCDA to Support Patient–Clinician Shared Decision-Making: The Case of the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the United States
INTRODUCTION: Well- or moderately differentiated gastroenteropancreatic neuroendocrine tumors (GEP-NETs) are often slow-growing, and some patients with unresectable, asymptomatic, non-functioning tumors may face the choice between watchful waiting (WW), or somatostatin analogues (SSA) to delay progr...
Autores principales: | Wagner, Monika, Samaha, Dima, Khoury, Hanane, O’Neil, William M., Lavoie, Louis, Bennetts, Liga, Badgley, Danielle, Gabriel, Sylvie, Berthon, Anthony, Dolan, James, Kulke, Matthew H., Goetghebeur, Mireille |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5778190/ https://www.ncbi.nlm.nih.gov/pubmed/29270780 http://dx.doi.org/10.1007/s12325-017-0653-1 |
Ejemplares similares
-
Applying Reflective Multicriteria Decision Analysis (MCDA) to Patient–Clinician Shared Decision-Making on the Management of Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) in the Spanish Context
por: Wagner, Monika, et al.
Publicado: (2018) -
Appraising the holistic value of Lenvatinib for radio-iodine refractory differentiated thyroid cancer: A multi-country study applying pragmatic MCDA
por: Wagner, Monika, et al.
Publicado: (2017) -
GASTROENTEROPANCREATIC NEUROENDOCRINE TUMORS (GEP-NETs) - APPROACH TO DIAGNOSIS AND MANAGEMENT
por: Oladejo, A.O.
Publicado: (2009) -
mTOR Pathway in Gastroenteropancreatic Neuroendocrine Tumor (GEP-NETs)
por: Zanini, Sara, et al.
Publicado: (2020) -
Impact of Nutritional Status on Gastroenteropancreatic Neuroendocrine Tumors (GEP-NET) Aggressiveness
por: Barrea, Luigi, et al.
Publicado: (2018)